Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study

DOI record: { "DOI": "10.3389/fnut.2020.613928", "ISSN": [ "2296-861X" ], "URL": "http://dx.doi.org/10.3389/fnut.2020.613928", "abstract": "<jats:p><jats:bold>Background:</jats:bold> Mounting evidence suggests SARS-CoV-2 may impact on host microbiota and gut inflammation, infecting intestinal epithelial cells. This possible link and its implications can be investigated by observing the effects of modulation of the microbial flora in patients with COVID-19. The aim of this study was to compare the rate of mortality, the need of ICU hospitalization and the length of hospitalization in patients with severe COVID-19 pneumonia who received the best available therapy (BAT) vs. patients treated with BAT and supplemented with oral bacteriotherapy.</jats:p><jats:p><jats:bold>Methods:</jats:bold> This retrospective, observational cohort study included 200 adults with severe COVID-19 pneumonia. All patients received therapeutic regimens including low molecular weight heparin plus one or more between hydroxychloroquine, azithromycin, antivirals, and Tocilizumab. Oral bacteriotherapy was used as complementary treatment.</jats:p><jats:p><jats:bold>Results:</jats:bold> Out of the 200 patients, 112 received BAT without oral bacteriotherapy, and 88 BAT with oral bacteriotherapy. Crude mortality was 22%. Eleven percent died in the group of patients treated with BAT plus oral bacteriotherapy vs. 30% subjects in the group of patients managed only with BAT (<jats:italic>p</jats:italic> &amp;lt; 0.001). By multivariate analysis, the age &amp;gt;65 years, CRP &amp;gt;41.8 mg/L, Platelets &amp;lt;150.000 mmc, and cardiovascular events were associated with the increased risk of mortality. Oral bacteriotherapy was an independent variable associated with a reduced risk for death. Despite large prospective trials are needed, this study highlights a possible role for oral bacteriotherapy in the management of patients hospitalized for COVID-19 pneumonia.</jats:p>", "alternative-id": [ "10.3389/fnut.2020.613928" ], "author": [ { "affiliation": [], "family": "Ceccarelli", "given": "Giancarlo", "sequence": "first" }, { "affiliation": [], "family": "Borrazzo", "given": "Cristian", "sequence": "additional" }, { "affiliation": [], "family": "Pinacchio", "given": "Claudia", "sequence": "additional" }, { "affiliation": [], "family": "Santinelli", "given": "Letizia", "sequence": "additional" }, { "affiliation": [], "family": "Innocenti", "given": "Giuseppe Pietro", "sequence": "additional" }, { "affiliation": [], "family": "Cavallari", "given": "Eugenio Nelson", "sequence": "additional" }, { "affiliation": [], "family": "Celani", "given": "Luigi", "sequence": "additional" }, { "affiliation": [], "family": "Marazzato", "given": "Massimiliano", "sequence": "additional" }, { "affiliation": [], "family": "Alessandri", "given": "Francesco", "sequence": "additional" }, { "affiliation": [], "family": "Ruberto", "given": "Franco", "sequence": "additional" }, { "affiliation": [], "family": "Pugliese", "given": "Francesco", "sequence": "additional" }, { "affiliation": [], "family": "Venditti", "given": "Mario", "sequence": "additional" }, { "affiliation": [], "family": "Mastroianni", "given": "Claudio M.", "sequence": "additional" }, { "affiliation": [], "family": "d'Ettorre", "given": "Gabriella", "sequence": "additional" } ], "container-title": "Frontiers in Nutrition", "container-title-short": "Front. Nutr.", "content-domain": { "crossmark-restriction": true, "domain": [ "frontiersin.org" ] }, "created": { "date-parts": [ [ 2021, 1, 11 ] ], "date-time": "2021-01-11T13:44:07Z", "timestamp": 1610372647000 }, "deposited": { "date-parts": [ [ 2021, 1, 13 ] ], "date-time": "2021-01-13T09:38:27Z", "timestamp": 1610530707000 }, "indexed": { "date-parts": [ [ 2024, 4, 8 ] ], "date-time": "2024-04-08T09:17:39Z", "timestamp": 1712567859607 }, "is-referenced-by-count": 54, "issued": { "date-parts": [ [ 2021, 1, 11 ] ] }, "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 1, 11 ] ], "date-time": "2021-01-11T00:00:00Z", "timestamp": 1610323200000 } } ], "link": [ { "URL": "https://www.frontiersin.org/articles/10.3389/fnut.2020.613928/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "1965", "original-title": [], "prefix": "10.3389", "published": { "date-parts": [ [ 2021, 1, 11 ] ] }, "published-online": { "date-parts": [ [ 2021, 1, 11 ] ] }, "publisher": "Frontiers Media SA", "reference": [ { "DOI": "10.1159/000509774", "article-title": "Gastrointestinal symptoms and outcomes in hospitalized COVID-19 patients", "author": "Ramachandran", "doi-asserted-by": "publisher", "first-page": "373", "journal-title": "Dig Dis.", "key": "B1", "volume": "38", "year": "2020" }, { "DOI": "10.1053/j.gastro.2020.04.017", "article-title": "Gastrointestinal symptoms and COVID-19: a case-control study from the United States", "author": "Nobel", "doi-asserted-by": "publisher", "first-page": "373", "journal-title": "Gastroenterology", "key": "B2", "volume": "159", "year": "2020" }, { "DOI": "10.1016/j.jcv.2020.104392", "article-title": "Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China", "author": "Zhang", "doi-asserted-by": "publisher", "first-page": "104392", "journal-title": "J Clin Virol.", "key": "B3", "volume": "127", "year": "2020" }, { "DOI": "10.22038/abjs.2020.47828.2361", "article-title": "Molecular aspects of co-morbidities in COVID-19 infection", "author": "Pouya", "doi-asserted-by": "publisher", "journal-title": "Arch Bone Jt Surg", "key": "B4", "year": "2020" }, { "DOI": "10.1016/j.arr.2020.101123", "article-title": "ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis", "author": "Viana", "doi-asserted-by": "publisher", "first-page": "101123", "journal-title": "Ageing Res Rev.", "key": "B5", "volume": "62", "year": "2020" }, { "DOI": "10.1111/liv.14481", "article-title": "Liver impairment associated with disease progression in COVID-19 patients", "author": "Chen", "doi-asserted-by": "publisher", "first-page": "2308", "journal-title": "Liver Int.", "key": "B6", "volume": "40", "year": "2020" }, { "DOI": "10.3389/fmed.2020.00389", "article-title": "Challenges in the management of SARS-CoV2 infection: the role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19", "author": "d'Ettorre", "doi-asserted-by": "publisher", "first-page": "389", "journal-title": "Front. Med.", "key": "B7", "volume": "7", "year": "2020" }, { "key": "B8", "unstructured": "Laboratory Testing for 2019 Novel Coronavirus (2019-nCoV) in Suspected Human Cases2020" }, { "key": "B9", "unstructured": "Handbook for the Care of People With COVID-19 Disease, Version 2.02020" }, { "DOI": "10.1016/0021-9681(87)90171-8", "article-title": "A new method of classifying prognostic comorbidity in longitudinal studies: development and validation", "author": "Charlson", "doi-asserted-by": "publisher", "first-page": "373", "journal-title": "J Chronic Dis.", "key": "B10", "volume": "40", "year": "1987" }, { "DOI": "10.1136/thorax.58.5.377", "article-title": "Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study", "author": "Lim", "doi-asserted-by": "publisher", "first-page": "377", "journal-title": "Thorax.", "key": "B11", "volume": "58", "year": "2003" }, { "DOI": "10.1197/j.aem.2007.02.036", "article-title": "Performance of severity of illness scoring systems in emergency department patients with infection", "author": "Howell", "doi-asserted-by": "publisher", "first-page": "709", "journal-title": "Acad Emerg Med.", "key": "B12", "volume": "14", "year": "2007" }, { "DOI": "10.1038/srep22911", "article-title": "Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency [published correction appears in Sci Rep", "author": "Liu", "doi-asserted-by": "publisher", "first-page": "22911", "journal-title": "Sci Rep", "key": "B13", "volume": "6", "year": "2016" }, { "DOI": "10.1056/NEJM199701233360402", "article-title": "A prediction rule to identify low-risk patients with community-acquired pneumonia", "author": "Fine", "doi-asserted-by": "publisher", "first-page": "243", "journal-title": "N Engl J Med.", "key": "B14", "volume": "336", "year": "1997" }, { "DOI": "10.1093/cid/ciaa414", "article-title": "Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score [published online ahead of print, 2020]", "author": "Ji", "doi-asserted-by": "publisher", "first-page": "1393", "journal-title": "Clin Infect Dis.", "key": "B15", "volume": "71", "year": "2020" }, { "DOI": "10.18632/aging.103631", "article-title": "Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China", "author": "Gao", "doi-asserted-by": "publisher", "first-page": "12504", "journal-title": "Aging (Albany NY).", "key": "B16", "volume": "12", "year": "2020" }, { "DOI": "10.1177/1753466620937170", "article-title": "Targeting the gut-lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection", "author": "Conte", "doi-asserted-by": "publisher", "first-page": "1753466620937170", "journal-title": "Ther Adv Respir Dis.", "key": "B17", "volume": "14", "year": "2020" }, { "DOI": "10.1111/cea.12723", "article-title": "Lung-gut cross-talk: evidence, mechanisms and implications for the mucosal inflammatory diseases", "author": "Tulic", "doi-asserted-by": "publisher", "first-page": "519", "journal-title": "Clin Exp Allergy.", "key": "B18", "volume": "46", "year": "2016" }, { "DOI": "10.1021/acsnano.0c03402", "article-title": "Considering the effects of microbiome and diet on SARS-CoV-2 infection: Nanotechnology roles", "author": "Kalantar-Zadeh", "doi-asserted-by": "publisher", "first-page": "5179", "journal-title": "ACS Nano.", "key": "B19", "volume": "14", "year": "2020" }, { "DOI": "10.18632/aging.102927", "article-title": "Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson's disease models", "author": "Castelli", "doi-asserted-by": "publisher", "first-page": "4641", "journal-title": "Aging (Albany NY).", "key": "B20", "volume": "12", "year": "2020" }, { "DOI": "10.1038/sj.gt.3301540", "article-title": "Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice", "author": "Hashiba", "doi-asserted-by": "publisher", "journal-title": "Gene Ther.", "key": "B21", "year": "2001" }, { "DOI": "10.4049/jimmunol.1601414", "article-title": "Heme oxygenase-1 modulates human respiratory syncytial virus replication and lung pathogenesis during infection", "author": "Espinoza", "doi-asserted-by": "publisher", "first-page": "212", "journal-title": "J Immunol.", "key": "B22", "volume": "199", "year": "2017" }, { "DOI": "10.1038/srep32176", "article-title": "Human heme oxygenase 1 is a potential host cell factor against dengue virus replication", "author": "Tseng", "doi-asserted-by": "publisher", "first-page": "32176", "journal-title": "Sci Rep.", "key": "B23", "volume": "6", "year": "2016" }, { "DOI": "10.1128/JVI.02422-13", "article-title": "The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication", "author": "Hill-Batorski", "doi-asserted-by": "publisher", "first-page": "13795", "journal-title": "J Virol.", "key": "B24", "volume": "87", "year": "2013" }, { "DOI": "10.1016/S2468-1253(20)30196-5", "article-title": "Probiotics and COVID-19", "author": "Ceccarelli", "doi-asserted-by": "publisher", "first-page": "721", "journal-title": "Lancet Gastroenterol Hepatol.", "key": "B25", "volume": "5", "year": "2020" }, { "DOI": "10.3390/nu12061718", "article-title": "Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: a scoping review", "author": "Infusino", "doi-asserted-by": "publisher", "first-page": "1718", "journal-title": "Nutrients.", "key": "B26", "volume": "12", "year": "2020" }, { "DOI": "10.1080/14712598.2019.1638907", "article-title": "Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS", "author": "Ceccarelli", "doi-asserted-by": "publisher", "first-page": "949", "journal-title": "Expert Opin Biol Ther.", "key": "B27", "volume": "19", "year": "2019" }, { "DOI": "10.18632/aging.103372", "article-title": "Lactate dehydrogenase, an independent risk factor of severe COVID- 19 patients: a retrospective and observational study", "author": "Han", "doi-asserted-by": "publisher", "first-page": "11245", "journal-title": "Aging.", "key": "B28", "volume": "12", "year": "2020" }, { "DOI": "10.1159/000507959", "article-title": "Constantinou C. A fragile balance: the important role of the intestinal microbiota in the prevention and management of colorectal cancer", "author": "Toumazi", "doi-asserted-by": "publisher", "first-page": "593", "journal-title": "Oncology.", "key": "B29", "volume": "98", "year": "2020" }, { "DOI": "10.3389/fimmu.2019.01551", "article-title": "The commensal microbiota and viral infection: a comprehensive review", "author": "Li", "doi-asserted-by": "publisher", "first-page": "1551", "journal-title": "Front Immunol", "key": "B30", "volume": "10", "year": "2019" }, { "DOI": "10.1089/ars.2020.8142", "article-title": "Is albumin predictor of mortality in COVID-19?", "author": "Violi", "doi-asserted-by": "publisher", "journal-title": "Antioxid Redox Signal", "key": "B31", "year": "2020" }, { "DOI": "10.1161/CIRCRESAHA.120.317173", "article-title": "Hypoalbuminemia, coagulopathy, and vascular disease in COVID-19", "author": "Violi", "doi-asserted-by": "publisher", "first-page": "400", "journal-title": "Circ Res.", "key": "B32", "volume": "127", "year": "2020" } ], "reference-count": 32, "references-count": 32, "relation": {}, "resource": { "primary": { "URL": "https://www.frontiersin.org/articles/10.3389/fnut.2020.613928/full" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Nutrition and Dietetics", "Endocrinology, Diabetes and Metabolism", "Food Science" ], "subtitle": [], "title": "Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study", "type": "journal-article", "update-policy": "http://dx.doi.org/10.3389/crossmark-policy", "volume": "7" }